Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis

Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis

Abstract Objective To assess the efficacy and tolerance of tocilizumab (TCZ) in giant cell arteritis (GCA) patients over 80. Method GCA patients over 80 years old from the French Study Group for Large Vessel Vasculitis register who received TCZ were analyzed. Results Twenty-one GCA patients (median...

Full description

Bibliographic Details
Main Authors: Hubert de Boysson, Maelle Le Besnerais, Félix Blaison, Aurélie Daumas, Pierre-André Jarrot, François Perrin, Nathalie Tieulié, Alexandre Maria, Pierre Duffau, Bruno Gombert, Maxime Samson, Olivier Espitia, Marc Lambert, Arsène Mékinian, Achille Aouba, for the French Study Group for Large Vessel Vasculitis (GEFA)
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Arthritis Research & Therapy
Subjects:
Giant cell arteritis
Tocilizumab
Elderly
Old patients
Efficacy
Safety
Online Access:https://doi.org/10.1186/s13075-021-02529-4

Internet

https://doi.org/10.1186/s13075-021-02529-4

Similar Items